Jorveza 0.5 mg, Schmelztabletten - 20 Swissmedic Key 66999003 Registration Holder Dr. Falk Pharma AG Name Jorveza 0.5 mg, Schmelztabletten Date of registration 25.05.2018 Introduction of Sequence 15.04.2021 ATC-Classification Budesonide (A07EA06) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 04.99. Show package size 20 Index Therapeuticus (Swissmedic) 04.99. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information Ex-factory-Price 72.43 Limitation Yes Limitation text
Deductible 10 % Consumer price 99.65 Feedback FB Daily cost GTIN 7680669990039 Medication Code Synthetika Pharmacode Disponibility
Composition budesonidum 0.5 mg, dinatrii citras sesquihydricus, natrii dihydrogenocitras anhydricus, natrii hydrogenocarbonas, sucralosum, povidonum K 25, natrii docusas, mannitolum, macrogolum 6000, magnesii stearas pro compresso corresp. natrium 25.62 mg. Packungsbestandteile Galenic Form Schmeltabletten Active Agent Dose Budesonide 0.5 mg
BAG: Active Agent Dose Budesonide 0.5 mg
Inactive agents Dose Dinatrii Citras Sesquihydricus Macrogol 6000 Magnesii Stearas pro Compresso Mannitol Natrii Dihydrogenocitras Anhydricus Natrii Docusas Sodium Hydrogen Carbonate Povidonum K 25 Sucralosum
Source Data was imported : 06.07.2022
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
